BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12580846)

  • 1. Quality improvement project in cervical cancer screening: practical measures for monitoring laboratory performance.
    Tarkkanen J; Geagea A; Nieminen P; Anttila A
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):82-8. PubMed ID: 12580846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland.
    Nieminen P; Hakama M; Tarkkanen J; Anttila A
    Int J Cancer; 2002 Jun; 99(5):732-6. PubMed ID: 12115508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Computer-assisted screening for cervical carcinoma--the results for a 10-year period].
    Neumann HG; Seidenschnur G
    Arch Geschwulstforsch; 1987; 57(2):129-39. PubMed ID: 3296989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six years' audit of laboratory workload and rates of referral for colposcopy in a cervical screening programme in three districts.
    Raffle AE; Alden B; Mackenzie EF
    BMJ; 1990 Oct; 301(6757):907-11. PubMed ID: 2261537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and development of an on-line quality assurance programme for colposcopy in a population-based cervical screening setting in Italy.
    Bucchi L; Cristiani P; Costa S; Schincaglia P; Garutti P; Sassoli de Bianchi P; Naldoni C; Olea O; Sideri M
    BMC Health Serv Res; 2013 Jun; 13():237. PubMed ID: 23809615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Increase of premalignant cervical lesions in teenagers.
    Punnonen R; Grönroos M; Peltonen R
    Lancet; 1974 Oct; 2(7886):949. PubMed ID: 4138326
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of colposcopy in Population Program of Cervical Cancer Early Detection].
    Wojciech R
    Ginekol Pol; 2007 Sep; 78(9):719-22. PubMed ID: 18159827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Status of screening tests for cervical cancer and its precancerous lesion].
    Zhao FH; Rong SD; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):638-41. PubMed ID: 12901114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines.
    Basu P; Nessa A; Majid M; Rahman JN; Ahmed T
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):131-4. PubMed ID: 20659365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant variation in performance does not reflect the effectiveness of the cervical cancer screening programme in Finland.
    Kotaniemi-Talonen L; Nieminen P; Hakama M; Seppänen J; Ikkala J; Martikainen J; Tarkkanen J; Toivonen T; Anttila A
    Eur J Cancer; 2007 Jan; 43(1):169-74. PubMed ID: 17049228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it relevant to screen women younger than 26 years for precancerous and malignant cervical lesions ?
    Ghosh A; Rao S; Pramanik T
    Asian Pac J Cancer Prev; 2005; 6(2):123-4. PubMed ID: 16101318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High lifetime probability of screen-detected cervical abnormalities.
    Pankakoski M; Heinävaara S; Sarkeala T; Anttila A
    J Med Screen; 2017 Dec; 24(4):201-207. PubMed ID: 28073308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
    Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
    BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cervical smears: towards an optimal screening for cervical cancer].
    Leroy JL; Boman F
    Presse Med; 2003 Feb; 32(4):174-80. PubMed ID: 12610474
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.